Metagenomi Inc. Common St... (MGX)
NASDAQ: MGX
· Real-Time Price · USD
1.87
-0.03 (-1.58%)
At close: Aug 15, 2025, 3:59 PM
1.84
-1.60%
After-hours: Aug 15, 2025, 07:49 PM EDT
Metagenomi Common Stock Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q1 2022 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Mar 31, 2022 |
Cash & Equivalents | 26.85M | 29.2M | 27.39M | 25.12M | 61.18M | 102.56M | 140.6M | 101.9M | 51.65M | -362.13M | 184.44M | n/a |
Short-Term Investments | 178.14M | 196.78M | 220.92M | 249.47M | 238.74M | 224.85M | 130.58M | 191.03M | 266.79M | 724.26M | 177.69M | n/a |
Long-Term Investments | 2.15M | 3.45M | 3.45M | 10.58M | 10.68M | 10.68M | 10.68M | 10.68M | 10.68M | n/a | 7.81M | n/a |
Other Long-Term Assets | 6.05M | 6.03M | 5.54M | 5.57M | 5.58M | 5.63M | 10.74M | 10.07M | 7.37M | -362.13M | 6.52M | -108.15M |
Receivables | 873K | 1.01M | 1.26M | 589K | 1.65M | 2.08M | 2.45M | 3.92M | 2.33M | n/a | 1.27M | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 619K | n/a | n/a | n/a |
Other Current Assets | 5.82M | 6.21M | 8.4M | 7.12M | 1.4M | 6.16M | 4.64M | 3.15M | 1.78M | n/a | 300K | n/a |
Total Current Assets | 211.68M | 233.19M | 257.96M | 282.29M | 307.58M | 335.64M | 278.27M | 300M | 324.24M | 362.13M | 366.9M | 108.15M |
Property-Plant & Equipment | 52.4M | 55.2M | 57.66M | 59.91M | 62.07M | 63.46M | 65.15M | 65.69M | 66.37M | n/a | 33.26M | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 60.6M | 64.67M | 66.64M | 76.06M | 78.33M | 79.76M | 86.57M | 86.43M | 84.42M | -362.13M | 47.59M | -108.15M |
Total Assets | 272.28M | 297.87M | 324.6M | 358.35M | 385.9M | 415.4M | 364.84M | 386.43M | 408.66M | n/a | 414.49M | n/a |
Account Payables | 2.89M | 2.67M | 533K | 3.1M | 3.45M | 6.84M | 1.79M | 4.89M | 2.99M | n/a | 2.01M | n/a |
Deferred Revenue | 18.94M | 25.5M | 22.76M | 29.05M | 32.98M | 48.29M | 48.07M | 48.22M | 46.01M | n/a | 33.94M | n/a |
Short-Term Debt | 5.51M | 5.6M | 5.59M | 4.7M | 5.4M | 4.38M | 212K | 2.27M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 8.81M | -2.19M | -246K | 878K | -677K | 11K | 1.07M | -1.29M | 50.39M | n/a | 37.12M | n/a |
Total Current Liabilities | 33.27M | 39.89M | 37.31M | 45.69M | 52.81M | 70.7M | 68.86M | 68.78M | 64.33M | n/a | 48.54M | n/a |
Long-Term Debt | 37.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -346.1M | n/a |
Other Long-Term Liabilities | 5.71M | 2.11M | 2.01M | 3.08M | 3.8M | 5.08M | 5.08M | 3.45M | -301.27M | n/a | -345.07M | -43.95M |
Total Long-Term Liabilities | 43.19M | 45.31M | 52.43M | 56.88M | 63.68M | 69.07M | 431.56M | 85.91M | 446.87M | n/a | 440.38M | -43.95M |
Total Liabilities | 76.45M | 85.21M | 89.74M | 102.58M | 116.49M | 139.77M | 500.43M | 505.45M | 511.2M | n/a | 488.91M | -43.95M |
Total Debt | 42.99M | 44.44M | 45.78M | 46.07M | 47.94M | 48.06M | 48.23M | 48.21M | 48.46M | n/a | 18.57M | n/a |
Common Stock | 4K | 4K | 4K | 4K | 4K | 4K | 26K | 26K | 3.72M | n/a | 2.54M | n/a |
Retained Earnings | -267.95M | -248.04M | -223M | -199.6M | -180.83M | -170.09M | -144.94M | -125.65M | -105.83M | n/a | -76.69M | n/a |
Comprehensive Income | 372K | 621K | 709K | 1.64M | -265K | -278K | -97K | 6.6M | -429K | -74.43M | -274K | -32.54M |
Shareholders Equity | 195.83M | 212.66M | 234.86M | 255.77M | 269.42M | 275.63M | 215.17M | 231.74M | -102.54M | 271.68M | -74.43M | 43.95M |
Total Investments | 180.3M | 200.22M | 224.37M | 260.05M | 249.42M | 235.52M | 141.25M | 201.71M | 277.47M | 724.26M | 185.5M | n/a |